- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03989063
Motor Learning in Individuals With Lower Limb Loss and Chronic Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Prior to participation in the study, the purpose and procedures of the study, including possible image and video recordings, will be explained to the subjects.
- Subjects will then be required to give written consent for their participation and will receive a copy of their consent form.
- The following 2-part research protocol uses a similar experimental protocol (learning a balance task) on individuals with leg amputation (Part 1), and individuals with chronic diabetes (Part 2).
Part 1:
The experiment will take place over a 3-day period including screening and baseline testing (Visit 1), balance training (Visits 2), and retention testing (Visit 3; at least 24 hours after Visit 2). On Visit 1, the investigators will assess aspects of health and functional capacity to assess participation eligibility and establish baseline characteristics of the participants. In addition to medical history and anthropometric measurements, the assessment will consist of clinical surveys of quality of life, physical activity level, balance confidence, and fear of falling. Ambulatory performance will be quantified. Additional amputee-specific measures will be used to assess functional characteristics unique to the population.
The balance training involves standing and maintaining balance on a stabilometer, which consists of a platform (1.3m long by 1.4m wide) connected to a single axis that allows bi-directional sway (Lafayette Instrument Co.; Figure 1). The maximum angular deviation of the platform is 18°. A safety harness is provided to prevent falls but does not provide support during the performance of the task. The load on the harness will be monitored with an S-type strain gauge (Delsys Inc., Massachusetts, USA) connected in series to the harness tether. Participants are required to maintain balance with feet in a medial-lateral orientation while standing on the balance board and looking straight ahead. A potentiometer monitors the sway angle of the platform. An integrated timer measures time in balance, which is defined as when the platform angle is within ± 5° of horizontal.[52] The primary outcome measure is time in balance (sec.) for each 30s trial. The secondary outcome measure is platform angular deviation from horizontal (RMSE; degree).
Participants will be assigned to receive the 2 attentional focus conditions in random order. Depending on the condition, participants will receive either internal or the external focus instruction on where to direct their attention while training to perform the balance task. During training, the assigned instruction will be reinforced at the beginning and after every 5 practice trials. After they complete training with the first condition, they will go through a washout period (at least 4 weeks) before receiving training under the other condition. Participants will be blinded to the purpose of the intervention and study design until debriefing at the end of the study.
The training will take place over a 2-day period (Visits 1 and 2), the investigators will monitor the changes in balance task performance over 40 total practice trials (20 trials each visit). The balance training consists of thirty 30s trials with a 90s rest interval between trials. During the rest interval, the platform will be locked to provide a stable surface or the participant can choose to step off the platform to sit down and rest when needed. After each 5 trials, participants will be given feedback regarding their performance (time in balance). No additional feedback will be provided. This protocol has been validated in the older adult population (mean age 69.4 years) in a previous study (Chiviacowsky et al. 2010). After each training block of 5 trials, the participant's self-perceived direction of attentional focus and spontaneous comments during the practice will be checked. The retention test will be performed at least 24 hours after the 2nd training day (Visit 3). The retention test will consist of performing 10 trials of the same balance task during which the participant will not receive any instructions, reminders, or feedback. An additional 10 trials of skill transfer task will be performed with an added cognitive task (counting numbers backward).
Part 2 (individuals with diabetes):
The procedure of Part 2 of this research is identical to Part 1. The main differences, in addition to the different participant population are described below.
In addition to the baseline health and functional capacity assessments as described in Part 1, the investigators will assess all participants' sensorimotor function using an established knee joint reposition sense test on a Cybex Norm dynamometer (Computer Sports Medicine Inc., Stoughton, MA, USA). This test assesses participant's ability to reproduce a joint angle using only proprioception. The test performance will be measured as the absolute error in degrees between the reproduced and target angles. This specific test was chosen to quantify the lower limb sensorimotor function because previous studies have shown it to be predictive of mobility outcomes in older adults in general and in those with diabetes. The investigators will determine individuals with diabetes-related sensorimotor impairment if the error is greater than 3.65°.
Individuals will be randomly assigned to receive either internal or external focus instructions conditions during the balance training. The experimental protocols and procedures will be the same as in Aim 1, including the screening (Visit 1), balance training (Visits 2), and retention and skill transfer testing (Visit 3; at least 24 hours after Visit 2).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Szu-Ping Lee, PhD
- Phone Number: 7028953086
- Email: szu-ping.lee@unlv.edu
Study Contact Backup
- Name: Szu-Ping Lee, PhD
- Phone Number: 3528704767
- Email: szupinglee@gmail.com
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89154
- Recruiting
- University of Nevada, Las Vegas
-
Contact:
- Szu-Ping Lee, PhD
- Phone Number: 702-895-3086
- Email: szu-ping.lee@unlv.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (amputees):
- Have unilateral transtibial or transfemoral amputation,
- Age >18 years,
- Are fitted with a walking prosthesis and use it regularly and proficiently (K-level of 2 or above, further defined as scoring higher than 50 percentile on the Prosthetic Limb Users Survey of Mobility),
- Able to stand for at least 5 minutes without using an assistive device or experiencing excessive fatigue
- Willing to travel to UNLV 6 times for training and testing.
The inclusion criteria (non-amputee older adults with and without chronic diabetes):
- Age >18 years,
- With or without a current diagnosis of type II diabetes
- Able to walk for at least 50 meters without assistance from other people,
- Able to stand for at least 5 minutes without using an assistive device or experiencing excessive fatigue
- Willing to travel to UNLV 6 times for training and testing. -
Exclusion Criteria:
- Have other concurrent central nervous system diseases that influence motor functions and balance.
- Have leg/foot ulcer or other conditions that cause pain during weight-bearing.
Have cardiovascular, respiratory or other critical health conditions that preclude moderate physical activity.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Amputees (External Focus)
Participants in this group will receive the external focus instruction on where to direct their attention while training to perform the balance task.
During training, the assigned instruction will be reinforced at the beginning and after every 5 practice trials.
|
During the balance task, the participants will receive instructions to focus on external targets (external focus group) vs. movement of the body (internal focus group).
|
|
Active Comparator: Amputees (Internal Focus)
Participants in this group will receive the internal focus instruction on where to direct their attention while training to perform the balance task.
During training, the assigned instruction will be reinforced at the beginning and after every 5 practice trials.
|
During the balance task, the participants will receive instructions to focus on external targets (external focus group) vs. movement of the body (internal focus group).
|
|
Experimental: Diabetes (External Focus)
Participants in this group will receive the external focus instruction on where to direct their attention while training to perform the balance task.
During training, the assigned instruction will be reinforced at the beginning and after every 5 practice trials.
|
During the balance task, the participants will receive instructions to focus on external targets (external focus group) vs. movement of the body (internal focus group).
|
|
Active Comparator: Diabetes (Internal Focus)
Participants in this group will receive the internal focus instruction on where to direct their attention while training to perform the balance task.
During training, the assigned instruction will be reinforced at the beginning and after every 5 practice trials.
|
During the balance task, the participants will receive instructions to focus on external targets (external focus group) vs. movement of the body (internal focus group).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in balance performance
Time Frame: Throughout the training period (2 days, up to 40 trials) and during the post-training tests
|
During each 30-second balance practice trial, time in balance which is defined as when the balance platform is within 5 degrees from horizontal will be measured in seconds.
A longer time in balance (up to 30 seconds) indicates better balance performance.
|
Throughout the training period (2 days, up to 40 trials) and during the post-training tests
|
|
Change in balance performance
Time Frame: Throughout the balance training period (2 days, up to 40 trials) and during the post-training tests
|
During each balance practice trial, average deviation of balance platform angle from horizontal will be measured in degrees.
Smaller deviation from horizontal indicates better balance performance.
|
Throughout the balance training period (2 days, up to 40 trials) and during the post-training tests
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in fall recovery performance
Time Frame: Before and after balance training. The after training assessment will be conducted 2-10 days after the conclusion of the balance training.
|
Rate of successful recovery from 10 trials of simulated tripping/slipping perturbation during walking on a treadmill will be measured in percentage.
Higher percentage of successful recovery indicates better fall recovery performance.
|
Before and after balance training. The after training assessment will be conducted 2-10 days after the conclusion of the balance training.
|
|
Change in fall recovery performance
Time Frame: Before and after the 2-day balance training. The after training assessment will be conducted 2-10 days after the conclusion of the balance training.
|
Trunk flexion angle during slipping/tripping (degrees).
Previous studies have shown that smaller trunk angle during simulated tripping/slipping is associated with successful fall recovery.
Smaller trunk flexion angle indicates better fall recovery performance.
|
Before and after the 2-day balance training. The after training assessment will be conducted 2-10 days after the conclusion of the balance training.
|
|
Change in fall recovery performance
Time Frame: Before and after the 2-day balance training. The after training assessment will be conducted 2-10 days after the conclusion of the balance training.
|
Trunk angular velocity during slipping/tripping (degree/second).
Previous studies have shown that slower trunk angle change (i.e.
lower trunk angular velocity) during simulated tripping/slipping is associated with successful fall recovery.
Slower trunk angular velocity indicates better fall recovery performance.
|
Before and after the 2-day balance training. The after training assessment will be conducted 2-10 days after the conclusion of the balance training.
|
|
Change in patient's self-reported outcomes
Time Frame: Throughout the balance training period (2 days, assessed every 5 practice trials).
|
Self-efficacy regarding the performance of the balance task is assessed using a 4-question survey.
An example question is: "How confident are you that you can keep yourself in balance for 15 out of 30 seconds?".
Participant's response to each question is measured using a 0-10 scale.
Higher confidence indicates greater self-efficacy.
|
Throughout the balance training period (2 days, assessed every 5 practice trials).
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Szu-Ping Lee, PhD, University of Nevada, Las Vegas
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1299365
- 1K01HD091449-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and Digestive...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Leiden University Medical CenterAndaluz Health ServiceCompletedDiabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes MellitusNetherlands, Spain
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
Clinical Trials on Instructions to perform a motor task (external vs. internal focus instructions)
-
Inonu UniversityCompleted
-
Büşra TamgüçIstanbul Nisantasi UniversityActive, not recruitingNeck Pain | Motor Learning | Home Exercise ProgramTurkey
-
University of SouthamptonCompleted
-
Kirsehir Ahi Evran UniversitesiCompletedPhysical Therapy TechniquesTurkey
-
Egas Moniz - Cooperativa de Ensino Superior, CRLFundação para a Ciência e a TecnologiaRecruitingHealthy | Healthy AgingPortugal